Page last updated: 2024-10-30

metformin and Anxiety Neuroses

metformin has been researched along with Anxiety Neuroses in 3 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
"Cigarette smoking is the leading cause of preventable disease and death in the United States, with more persons dying from nicotine addiction than any other preventable cause of death."3.88Activation of AMPK by metformin improves withdrawal signs precipitated by nicotine withdrawal. ( Blendy, JA; Brynildsen, JK; Jin, S; Kim, SF; Lee, BG; Perron, IJ, 2018)
" A low prevalence of AD in patients with T2D was associated with residency in urban areas, the comorbidity of hemiplegia or paraplegia, the usage of metformin and sulfonylureas, and rapid-acting insulin injection therapy."3.85Prevalence of anxiety disorder in patients with type 2 diabetes: a nationwide population-based study in Taiwan 2000-2010. ( Hsieh, HM; Huang, CJ; Jiang, HJ; Lin, CH; Tu, HP; Wang, PW, 2017)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brynildsen, JK1
Lee, BG1
Perron, IJ1
Jin, S1
Kim, SF1
Blendy, JA1
Tu, HP1
Lin, CH1
Hsieh, HM1
Jiang, HJ1
Wang, PW1
Huang, CJ1
Reddy, BR1
Maitra, S1
Jhelum, P1
Kumar, KP1
Bagul, PK1
Kaur, G1
Banerjee, SK1
Kumar, A1
Chakravarty, S1

Other Studies

3 other studies available for metformin and Anxiety Neuroses

ArticleYear
Activation of AMPK by metformin improves withdrawal signs precipitated by nicotine withdrawal.
    Proceedings of the National Academy of Sciences of the United States of America, 2018, 04-17, Volume: 115, Issue:16

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Anxiety Disorders; Drug Evaluati

2018
Prevalence of anxiety disorder in patients with type 2 diabetes: a nationwide population-based study in Taiwan 2000-2010.
    The Psychiatric quarterly, 2017, Volume: 88, Issue:1

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Ambulatory Care; Anxiety Disorders; Cerebrovascular Dis

2017
Sirtuin 1 and 7 mediate resveratrol-induced recovery from hyper-anxiety in high-fructose-fed prediabetic rats.
    Journal of biosciences, 2016, Volume: 41, Issue:3

    Topics: Animals; Antioxidants; Anxiety Disorders; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes M

2016